Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines

NCT05925127 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

994

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: NVX-CoV2373 (5μg)
BIOLOGICAL: NVX-CoV2601 (5μg)
BIOLOGICAL: NVX-CoV2601(5μg)
BIOLOGICAL: NVX-CoV2601 (35μg)
BIOLOGICAL: NVX-CoV2601(35μg)
BIOLOGICAL: NVX-CoV2601(50μg)
BIOLOGICAL: Bivalent BA.4/5

Sponsor

Novavax